Cargando…
PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity
Osteosarcoma (OS) is a highly aggressive pediatric bone cancer in which most tumor cells remain immature and fail to differentiate into bone-forming osteoblasts. However, OS cells readily respond to adipogenic stimuli suggesting they retain mesenchymal stem cell-like properties. Here we demonstrate...
Autores principales: | Basu-Roy, Upal, Han, Eugenia, Rattanakorn, Kirk, Gadi, Abhilash, Verma, Narendra, Maurizi, Giulia, Gunaratne, Preethi H., Coarfa, Cristian, Kennedy, Oran D., Garabedian, Michael J., Basilico, Claudio, Mansukhani, Alka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308629/ https://www.ncbi.nlm.nih.gov/pubmed/27528232 http://dx.doi.org/10.18632/oncotarget.11273 |
Ejemplares similares
-
Sox2 is required for tumor development and cancer cells proliferation in osteosarcoma
por: Maurizi, Giulia, et al.
Publicado: (2018) -
The Effect of Fluid Flow Shear Stress and Substrate Stiffness on Yes-Associated Protein (YAP) Activity and Osteogenesis in Murine Osteosarcoma Cells
por: Coughlin, Thomas R., et al.
Publicado: (2021) -
The transcription factor Sox2 is required for osteoblast self-renewal
por: Basu-Roy, Upal, et al.
Publicado: (2010) -
Sox2 maintains self-renewal of tumor initiating cells in osteosarcomas
por: Basu-Roy, Upal, et al.
Publicado: (2011) -
Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)–Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts
por: Mansukhani, Alka, et al.
Publicado: (2000)